Elizabeth Rose, MD
Dermatology · Hattiesburg, MSNPI 1790926780
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,347 of the $21,437 with a category attached, or 80.9%. 43 manufacturers reported payments, led by AbbVie at 34.9% of the total.
Across 1,140 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Novartis$3K
- Merz North America, Inc.$1K
- Sanofi$1K
- Johnson & Johnson$814
- Galderma Laboratories, L.p.$812
- plus $7K from 37 others
What the payments were for
- Speaking & faculty fees$3,00014%
- Travel & lodging$8914%
- Food & beverage$17,34781%
- Education$1991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$500
- COSENTYX$220
- ILUMYA$161
- BLU-U$161
- ODOMZO$161
- Winlevi$161
- ABSORICA LD$161
- BOTOX$136
How this compares
$21,437 in reported general payments places this provider in the 85th percentile of 78 dermatology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 11 | $84,596 |
| Dupixent SyringeDupilumab | 14 | $51,873 |
| Ketoconazole | 222 | $3,268 |
| Clobetasol Propionate | 24 | $1,442 |
| Triamcinolone Acetonide | 82 | $1,145 |
| Betamethasone Valerate | 31 | $1,036 |
| Tacrolimus | 15 | $1,034 |
| Hydroxychloroquine Sulfate | 13 | $747 |
| Finasteride | 52 | $635 |
| Ciclopirox | 20 | $605 |
| Fluocinonide | 12 | $485 |
| Fluconazole | 20 | $429 |
| Betamethasone Dipropionate | 12 | $358 |
| Imiquimod | 15 | $352 |
| Dutasteride | 11 | $347 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hattiesburg
- Maureen OffiahHattiesburg$275K
- Steven ShapiroHattiesburg$165K
- William WallerHattiesburg$19K
- Mark GallardoHattiesburg$15K
- Stephen ConerlyHattiesburg$4K
- Rebecca DuffHattiesburg$1K
- Jeremy JacksonJackson$450K
- Lindsey ZubritskyOcean Springs$349K
- Lyndsay ShippOxford$246K
- Joseph TerracinaGreenville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.